ACADIA Pharmaceuticals Inc.'s (ACAD) CEO Stephen Davis at 39th Annual J.P. Morgan Healthcare Conference (Transcript)Seeking Alpha • 01/12/21
Acadia Pharmaceuticals to Present at the 39th Annual J.P. Morgan Healthcare Conference on January 12, 2021Business Wire • 12/22/20
ACADIA Pharmaceuticals Inc.'s (ACAD) Management Presents at 2020 Stifel Virtual Healthcare Conference (Transcript)Seeking Alpha • 11/18/20
Acadia Pharmaceuticals to Present at the Stifel 2020 Virtual Healthcare Conference on November 17, 2020Business Wire • 11/10/20
ACADIA Pharmaceuticals Inc.'s (ACAD) CEO Steve Davis on Q3 2020 Results - Earnings Call TranscriptSeeking Alpha • 11/05/20
Acadia Pharmaceuticals to Present New Scientific Data on Pimavanserin in Neurodegenerative Diseases at the 13th Clinical Trials on Alzheimer's Disease (CTAD) ConferenceBusiness Wire • 10/26/20
Acadia Pharmaceuticals to Announce Third Quarter 2020 Financial Results on November 4, 2020Business Wire • 10/21/20
Acadia Pharmaceuticals Appoints Elizabeth Garofalo, M.D. to Board of DirectorsBusiness Wire • 10/01/20
ACADIA Pharmaceuticals, Inc. (ACAD) CEO Steve Davis Presents at Cantor Virtual Global Healthcare Conference (Transcript)Seeking Alpha • 09/16/20
ACADIA Pharmaceuticals Inc. (ACAD) CEO Steve Davis Presents at Morgan Stanley 18th Annual Global Healthcare Conference (Transcript)Seeking Alpha • 09/14/20
(ACAD) Alert: Johnson Fistel Announces Shareholder Class Action Against ACADIA Pharmaceuticals Survives Motion to Dismiss; Should Management be Held Accountable for Investors Losses?PRNewsWire • 09/05/20